Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.
Clinical trial NCT03418558 · UNKNOWN
Trial details
- NCT number
- NCT03418558
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-08
- Primary completion
- 2019-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.